ELAVL2 and glioblastoma: Next, to determine whether ELAVL2-low GBM cells are indeed close to the MES phenotype, we performed immunocytochemistry of the EMT markers – E-cadherin (green) and Vimentin (red) – on GBM14, GBM28, and GBM30.